Colgate-Palmolive (NYSE:CL) was upgraded by research analysts at Macquarie from a “neutral” rating to an “outperform” rating in a research note issued on Tuesday, Marketbeat Ratings reports. The firm currently has a $81.00 price objective on the stock. Macquarie’s target price suggests a potential upside of 8.22% from the company’s previous close.
Several other analysts have also commented on CL. Zacks Investment Research raised Colgate-Palmolive from a “hold” rating to a “buy” rating and set a $80.00 price objective for the company in a report on Monday, September 25th. Royal Bank of Canada reaffirmed a “hold” rating and issued a $74.00 price objective on shares of Colgate-Palmolive in a report on Sunday, October 8th. Morgan Stanley raised Colgate-Palmolive from an “equal weight” rating to an “overweight” rating and lifted their price objective for the stock from $75.00 to $84.00 in a report on Monday, September 25th. Jefferies Group cut their price objective on Colgate-Palmolive from $79.00 to $76.00 and set a “hold” rating for the company in a report on Monday, October 30th. Finally, Stifel Nicolaus set a $73.00 price objective on Colgate-Palmolive and gave the stock a “hold” rating in a report on Sunday, October 29th. Three investment analysts have rated the stock with a sell rating, thirteen have assigned a hold rating and five have issued a buy rating to the company’s stock. Colgate-Palmolive has an average rating of “Hold” and a consensus target price of $76.33.
Colgate-Palmolive (CL) traded up $0.86 during trading on Tuesday, hitting $74.85. The company’s stock had a trading volume of 4,195,150 shares, compared to its average volume of 3,390,000. The company has a market cap of $65,730.00, a price-to-earnings ratio of 25.80, a price-to-earnings-growth ratio of 3.39 and a beta of 0.81. Colgate-Palmolive has a twelve month low of $63.43 and a twelve month high of $77.27. The company has a current ratio of 1.23, a quick ratio of 0.92 and a debt-to-equity ratio of 24.42.
In other news, CMO Mukul Deoras sold 7,500 shares of the business’s stock in a transaction dated Friday, November 10th. The stock was sold at an average price of $73.28, for a total value of $549,600.00. Following the transaction, the chief marketing officer now directly owns 45,217 shares in the company, valued at $3,313,501.76. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Victoria L. Dolan sold 9,000 shares of the business’s stock in a transaction dated Tuesday, November 14th. The shares were sold at an average price of $73.41, for a total value of $660,690.00. The disclosure for this sale can be found here. Insiders have sold 181,048 shares of company stock worth $13,168,995 over the last quarter. 1.02% of the stock is owned by company insiders.
Several institutional investors have recently made changes to their positions in the company. Stifel Financial Corp lifted its position in shares of Colgate-Palmolive by 0.8% in the first quarter. Stifel Financial Corp now owns 303,934 shares of the company’s stock worth $22,250,000 after buying an additional 2,360 shares in the last quarter. ARS Investment Partners LLC lifted its position in shares of Colgate-Palmolive by 0.5% in the first quarter. ARS Investment Partners LLC now owns 35,531 shares of the company’s stock worth $2,601,000 after buying an additional 175 shares in the last quarter. Wayne Hummer Investments L.L.C. purchased a new stake in shares of Colgate-Palmolive in the first quarter worth about $553,000. Victory Capital Management Inc. lifted its position in shares of Colgate-Palmolive by 77.1% in the first quarter. Victory Capital Management Inc. now owns 46,933 shares of the company’s stock worth $3,435,000 after buying an additional 20,432 shares in the last quarter. Finally, Schroder Investment Management Group lifted its position in shares of Colgate-Palmolive by 0.5% in the first quarter. Schroder Investment Management Group now owns 1,505,854 shares of the company’s stock worth $110,274,000 after buying an additional 7,850 shares in the last quarter. Institutional investors and hedge funds own 72.84% of the company’s stock.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
